aztreonam has been researched along with Travel Sickness in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mittal, J | 1 |
| Szymczak, WA | 1 |
| Guo, Y | 1 |
| Levi, MH | 1 |
| Chen, L | 1 |
| Kreiswirth, BN | 1 |
| Riska, PF | 1 |
| Nori, P | 1 |
1 other study available for aztreonam and Travel Sickness
| Article | Year |
|---|---|
Two for the price of one: emerging carbapenemases in a returning traveller to New York City.
Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Ceftazidim | 2018 |